Skip to main content

Table 2 Mutations in genes involved in the PI3K-AKT-mTOR pathway identified in the ten patients with macrocephaly and DD/ASD

From: Identification of mutations in the PI3K-AKT-mTOR signalling pathway in patients with macrocephaly and developmental delay and/or autism

Patient ID

Gene

Nucleotide change

Amino acid change

Inheritance

Mutation type

Allelic count in ExAC

No. of cases in COSMIC

Reported mutation

1

PIK3CA

c.G263A

p.(Arg88Gln)

De novo

Mosaic

0

137

43

2

PIK3CA

c.G1030A

p.(Val344Met)

Maternal

Germline

0

15

27

3

PTEN

c.G314T

p.(Cys105Phe)

De novo

Germline

0

6

39b

c.G492T

p.(Lys164Asn)

Maternal

Germline

1 in 120,466

0b

 

4

PTEN

c.G509C

p.(Ser170Thr)

De novo

Germline

0

0b

35.36b

5a

MTOR

c.G5395A

p.(Glu1799Lys)

De novo

Germline

0

10

28.45

6

PTEN

c.546delA

p.(Lys183ArgfsTer16)

De novo

Germline

0

0b

 

7

PPP2R5D

c.G592A

p.(Glu198Lys)

De novo

Germline

0

1

29.46

8

PPP2R5D

c.G592A

p.(Glu198Lys)

De novo

Germline

0

1

29.46

9

PIK3CA

c.G2740A

p.(Gly914Arg)

De novo

Mosaic

0

2

25.27

10

PTEN

c.A203G

p.(Tyr68Cys)

De novo

Germline

0

4

37.38

  1. The COSMIC database (June 2017) was accessed to retrieve the number of somatic mutations identified in cancer samples
  2. aThis patient was reported in a previous study [28] with the patient ID LR15-065
  3. bOther mutations in the same codon have been reported